期刊文献+

经皮腔内冠状动脉成形术后内皮素心脏释放动力学的研究 被引量:1

Study on the heart release kinetics of endothelin after percutaneous transluminal coronary angioplasty(PTCA)
下载PDF
导出
摘要 目的 对经皮腔内冠状动脉成形术 (PTCA)后内皮素 (ET)释放的动力学进行估价 ,探讨冠状动脉内皮是否是ET的释放部位。方法  12例冠脉造影前后、2 0例陈旧性心肌梗死行择期PTCA术前及术后 5min、6h的股静脉血、冠状动脉口血及冠状窦处血 ,用放射免疫法检测ET浓度。结果 冠脉造影前后血浆ET浓度无明显变化 (P >0 0 5 )。PTCA术后 5minET浓度升高 ,与术前相比具有极显著性差异 (P <0 0 1) ,且持续升高达 6h ,与术前相比具有极显著性差异 (P <0 0 1)。PTCA后冠状动脉口、冠状窦及股静脉处ET浓度均明显升高 ,但冠状窦处最高 ,其与冠状动脉口及股静脉相比均具有显著性差异 ,且冠状动脉口与股静脉处ET浓度相比也具有显著性差异。结论 PTCA可使血浆ET进一步升高 。 Objective This study was designed to assess the release kinetics of endothelin after percutaneous transluminal coronary angioplasty(PTCA) and to prove the coronary endothelium as the source of the endothelin release.Methods 20 patients with outmoded myocardial infarction (OMI) underwent PTCA and 12 patients accepted coronary angiography.Blood samples were withdrawn from the peripheral vein,coronary sinus(CS),coronary artery(CA) and femoral vein (V) before operation and 5 minutes,6 hours after operation.Concentration of plasma endothelin were determined by radioimmunoassay.Results The PTCA group had more level of plasma endothelin.There was no significant difference between pre-CAG and post-CAG ( P >0 05).The levels of plasma endothelin in PTCA increased significantly at 5 minutes and 6 hours ( P <0 01) after PTCA.The concentration of endothelin in coronary sinus was the highest.There was significant difference between CS and CA ( P <0 01) and between CS and V ( P <0 01). Conclusion Levels of plasma endothelin increased significantly after PTCA and coronary endothelium might be the source of the endothelin release.
出处 《中国急救医学》 CAS CSCD 北大核心 2004年第5期316-317,共2页 Chinese Journal of Critical Care Medicine
基金 北京市科技基金资助项目 (No .H0 10 2 10 3 3 0 113 )
关键词 冠状动脉成形术 冠脉内皮 内皮缩血管肽 Percutaneous transluminal coronary angioplasty(PTCA) Coronary endothelium Endothelin
  • 相关文献

参考文献7

  • 1Yanagisawa M,Kurihara H,Kimura S.A novel potent vasoconstrictor peptide produced by vascular endothelial cell[J].Nature,1988,332:411-415. 被引量:1
  • 2Rakugi H,Tabuchi Y,Nakamura M.Evidence of endothelin-l release from resistance vessels of rats in response to hypoxia[J].Biochem Biophy Res Commun,1990,169:973-977. 被引量:1
  • 3Sugiura M,Inagami T,Kon V.Endotoxin stimulates endothelin release in vivo and vitro as determined by radioimmunoassay[J].Biochem Biophy Res Commun,1989,161:1220-1227. 被引量:1
  • 4Malatino LS,Grassi R,Stancanelli B.Release of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplasty[J].Am Heart J,1993,126:700-702. 被引量:1
  • 5Yao Z,Gross GJ.A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs.Efficacy,time course,and role of KATP channels[J].Circulation,1994,89(3):1229-1236. 被引量:1
  • 6Masaki T,Kimura S,Yanagisawa M,et al.Molecular and cellular mechanisms of endothelin regulation.Implications for vascular function[J].Circulation,1991,84:1457-1468. 被引量:1
  • 7Power RF,Wharton J,Salas SP,et al.Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries[J].Eur J Pharmacol,1989,160:199-200. 被引量:1

同被引文献15

  • 1陆平,盛净.内皮素受体抗体与PTCA术后再狭窄的防治[J].心血管病学进展,2004,25(5):387-389. 被引量:5
  • 2王秀红,路方红.内皮素、一氧化氮与心血管疾病[J].中国慢性病预防与控制,2005,13(3):139-141. 被引量:32
  • 3刘勃,胡大一,唐朝枢,汪丽蕙.内皮素抗血清对大鼠主动脉球囊损伤后内膜增生的影响[J].中华心血管病杂志,1995,23(6):460-462. 被引量:15
  • 4Masaki T. The discovery of endothelins[J]. Cardiovasc Res, 1998, 39(3) :530-533. 被引量:1
  • 5Rubanyi GM, Polokoff MA. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, andpathophysiology [ J ]. Pharmacol Rev,1994,46(3) :325-415. 被引量:1
  • 6Meidan R, Clipper E, Gilboa T, et al. Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain[J]. Biol Chem, 2005,280(49) : 40867-40874. 被引量:1
  • 7Harris AK, Hutchinson JR, Sachidanandam K, et al. Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1 dlabetes[J]. Diabetes, 2005,54(9) : 2638-2644. 被引量:1
  • 8Bauters C, Meurice T, Hamon M, et al. Mechanisms and prevention of restenosis: from experimental models to clinical practice[J]. Cardiovasc Res, 1996,31(6) : 835-846. 被引量:1
  • 9Rensing BJ, Vos J, Smits PC, et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up[J]. Eur Heart J,2001,22(22)2125-2130. 被引量:1
  • 10Mosea JW, O'Shaughnessy C, Capito R, et al. The US multicenter, randomized, double blind study of the sirolimus-eluting stent in coronary lesions: safety out comes at 9 months[J].Eur Heart J,2002,23(Suppl) : 264. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部